Opposing roles of ERα and ERβ in the genesis and progression of adenocarcinoma in the rat ventral prostate

Prostate

Volumn 72, Issue 9, 2012, Pages 1013-1022

  Attia, D M A ^a   Ederveen, A G H ^a  

^a MSD   (Netherlands)

Author keywords

ER ; ER ; PIN; prostate

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA 45; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA 26; HORMONE RECEPTOR STIMULATING AGENT; PLACEBO; TESTOSTERONE 4 BUTYLCYCLOHEXANECARBOXYLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER MODEL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATE VENTRAL LOBE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RAT;

ADENOCARCINOMA; ANIMALS; DISEASE PROGRESSION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MALE; PROSTATE; PROSTATIC NEOPLASMS; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TESTOSTERONE;

EID: 84861098741     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21507     Document Type: Article

References (40)

1. Harlan LC, Potosky A, Gilliland FD, Hoffman R, Albertsen PC, Hamilton AS, Eley JW, Stanford JL, Stephenson RA,. Factors associated with initial therapy for clinically localized prostate cancer: Prostate cancer outcomes study. J Natl Cancer Inst 2001; 93 (24): 1864-1871.
2. Bostwick DG, Liu L, Brawer MK, Qian J,. High-grade prostatic intraepithelial neoplasia. Rev Urol 2004; 6 (4): 171-179.
3. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I,. Estradiol in elderly men. Aging Male 2002; 5 (2): 98-102.
4. Baulieu EE,. Androgens and aging men. Mol Cell Endocrinol 2002; 198 (1-2): 41-49.
5. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y, Risbridger GP,. Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J 2008; 22 (5): 1512-1520.
6. Ricke WA, Wang Y, Cunha GR,. Steroid hormones and carcinogenesis of the prostate: The role of estrogens. Differentiation 2007; 75 (9): 871-882.
7. Bernoulli J, Yatkin E, Laakso A, Anttinen M, Bosland M, Vega K, Kallajoki M, Santti R, Pylkkanen L,. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat. Prostate 2008; 68 (7): 728-739.
8. Bosland MC,. Sex steroids and prostate carcinogenesis: Integrated, multifactorial working hypothesis. Ann NY Acad Sci 2006; 1089: 168-176.
9. Hu WY, Shi GB, Lam HM, Hu DP, Ho SM, Madueke IC, Kajdacsy-Balla A, Prins GS,. Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells. Endocrinology 2011; 152 (6): 2150-2163.
10. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A,. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 2001; 61 (18): 6777-6782.
11. Denis L, Morton MS, Griffiths K,. Diet and its preventive role in prostatic disease. Eur Urol 1999; 35 (5-6): 377-387.
12. Hogan AM, Collins D, Sheehan K, Zierau O, Baird AW, Winter DC,. Rapid effects of phytoestrogens on human colonic smooth muscle are mediated by oestrogen receptor beta. Mol Cell Endocrinol 2010; 320 (1-2): 106-110.
13. Sar M, Welsch F,. Oestrogen receptor alpha and beta in rat prostate and epididymis. Andrologia 2000; 32 (4-5): 295-301.
14. Royuela M, de Miguel MP, Bethencourt FR, Sánchez-Chapado M, Fraile B, Arenas MI, Paniagua R,. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate. J Endocrinol 2001; 168 (3): 447-454.
15. Bonkhoff H, Berges R,. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur Urol 2008; 55 (3): 533-542.
16. Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao Y, McNeal JE, Ho SM,. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. Am J Pathol 2004; 164 (6): 2003-2012.
17. Imamov O, Morani A, Shim GJ, Omoto Y, Thulin-Andersson C, Warner M, Gustafsson JA,. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci USA 2004; 101 (25): 9375-9380.
18. Risbridger GP, Ellem SJ, McPherson SJ,. Estrogen action on the prostate gland: A critical mix of endocrine and paracrine signaling. J Mol Endocrinol 2007; 39 (3): 183-188.
19. Ellem SJ, Risbridger GP,. Treating prostate cancer: A rationale for targeting local oestrogens. Nature Rev Cancer 2007; 7 (8): 621-627.
20. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS,. REDUCE Study Group. Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010; 362 (13): 1192-1202.
21. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr., The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349 (3): 215-224.
22. Roa J, Vigo E, Castellano JM, Gaytan F, Navarro VM, Aguilar E, Dijcks FA, Ederveen AG, Pinilla L, van Noort PI, Tena-Sempere M,. Opposite roles of estrogen receptor (ER)-alpha and ERbeta in the modulation of luteinizing hormone responses to kisspeptin in the female rat: Implications for the generation of the preovulatory surge. Endocrinology 2008; 149 (4): 1627-1637.
23. Carruba G,. Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario. J Cell Biochem 2007; 102 (4): 899-911.
24. Sciarra F, Toscano V,. Role of estrogens in human benign prostatic hyperplasia. Arch Androl 2000; 44 (3): 213-220.
25. Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B,. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 1986; 76 (1): 45-48.
26. Ho SM, Leav I, Merk FB, Yu M, Kwan PW, Ziar J,. Induction of atypical hyperplasia, apoptosis, and type II estrogen- binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta. Lab Invest 1995; 73 (3): 356-365.
27. Prins GS, Korach KR,. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 2008; 73 (3): 233-244.
28. McPherson SJ, Wang H, Jones ME, Pedersen J, Iismaa TP, Wreford N, Simpson ER, Risbridger GP,. Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology 2001; 142 (6): 2458-2467.
29. Ayala AG, Ro JY,. Prostatic intraepithelial neoplasia: Recent advances. Arch Pathol Lab Med 2007; 131 (8): 1257-1266.
30. Godoy G, Taneja SS,. Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia. Prostate Cancer and Prostatic Dis 2008; 11 (1): 20-31.
31. Noble RL,. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977; 37 (6): 1929-1933.
32. Noble RL,. Prostate carcinoma of the Nb rat in relation to hormones. Int Rev Exp Pathol 1982; 23: 113-159.
33. Wang Y, Hayward SW, Donjacour AA, Young P, Jacks T, Sage J, Dahiya R, Cardiff RD, Day ML, Cunha GR,. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res 2000; 60 (21): 6008-6017.
34. Cunha GR, Hayward SW, Wang YZ, Ricke WA,. Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 2003; 107 (1): 1-10.
35. Bosland MC, Ford H, Horton L,. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Carcinogenesis 1995; 16 (6): 1311-1317.
36. McPherson SJ,. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 2007; 148 (2): 566-574.
37. Mirõ AM, Sastre-Serra J, Pons DG, Valle A, Roca P, Oliver J,. 17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol 2011; 123 (3-5): 133-139.
38. Thompson IM, Klein EA, Lippman SM, Coltman CA, Djavan B,. Prevention of prostate cancer with finasteride: US/European perspective. Eur Urol 2003; 44 (6): 650-655.
39. Malkowicz SB,. The role of diethylstilbestrol in the treatment of prostate cancer. Urology 2001; 58 (2 Suppl 1) 108-113.
40. Miceli V, Cocciadiferro L, Fregapane M, Zarcone M, Montalto G, Polito LM, Agostara B, Granata OM, Carruba G,. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression. OMICS 2011; (epub ahead of publication).